{
  "id": 12771908,
  "title": "FDA: Mifepristone review won't be done until March",
  "url": "https://urgent.news/2026/10/08/fda-mifepristone-review-wont-be-done-until-march",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-08T02:33:30.000Z",
  "source": {
    "name": "The Hill",
    "slug": "the-hill",
    "url": "https://thehill.com/policy/healthcare/6135515-fda-mifepristone-abortion-pill-review-delay/"
  },
  "original_language": "en",
  "account": null,
  "summary": "The Food and Drug Administration (FDA) won’t publish its safety review of the abortion drug mifepristone until March, it disclosed in a Wednesday court filing, adding that it won’t impose any new restrictions on the pill before that point. The revelations are likely to further anger anti-abortion activists, who have been losing patience with the...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}